Pfizer Share Price

Pfizer

CMP as on 24-May-22 15:49

₹ 4,260.40
-151.60 -3.44%

Open

₹ 4,400.00

Turnover (lac)

₹ 627

Prev. Close

₹ 4,412.00

Day's Vol (shares)

₹ 14,708

Day's Range (₹)

₹ 4,215.00
₹ 4,403.60

CMP as on24-May-22 15:43

₹ 4,258.60
-148.75 -3.38%

Open

₹ 4,395.30

Turnover (lac)

₹ 48

Prev. Close

₹ 4,407.35

Day's Vol (shares)

₹ 654

Day's Range

₹ 4,225.85
₹ 4,395.30

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 10-May-2022 - -
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022 inter alia to consider and approve a meeting of the Board of Directors of the Company is scheduled to be held on Friday May 20 2022 inter alia to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31 2022 and to consider recommendation of dividend if any for the Financial Year ended March 31 2022. Pursuant to the Pfizer Limited - Code of Internal Procedures and Conduct to Regulate Monitor and Report Trading by Insiders the Trading Window of the Company was closed from Thursday March 31 2022 (close of business) till 48 hours after the results are made public on May 20 2022. We request you to kindly take the same on record. The Board of Directors have at its Meeting held today, i.e., May 20, 2022, recommended a dividend of Rs. 35/- per equity share of Rs. 10/- each {350%) for the financial year ended March 31, 2022. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 23, 2022. (As Per BSE Announcement Dated on 20.05.2022)
Board Meeting - 24-Jan-2022 - -
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2022 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday February 3 2022 inter alia to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31 2021. Pursuant to the Pfizer Limited - Code of Internal Procedures and Conduct to Regulate Monitor and Report Trading by Insiders the Trading Window of the Company was closed from Friday December 31 2021 (close of business) till 48 hours after the results are made public on February 3 2022. We request you to kindly take the same on record. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the third quarter and nine months ended December 31, 2021, which were approved by the Board of Directors of the Company at its meeting held today, that commenced at 12.30 p.m. and concluded at 4.15 p.m. Also please find enclosed the Limited Review Report by our Auditors - M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record. Pfizer Limited - Outcome of the Board Meeting held on February 3, 2022 (As Per BSE Announcement dated on 03.02.2022)
Board Meeting - 25-Oct-2021 - -
Quarterly Results Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we submit herewith the unaudited financial results for the quarter and half year ended September 30, 2021, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 4.00 p.m. and concluded at 6.00 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record. (As Per BSE Announcement dated on 03.11.2021)
Board Meeting - 16-Jul-2021 - -
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, July 28, 2021, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2021. Pursuant to the Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders, the Trading Window of the Company was closed from Wednesday, June 30, 2021 (close of business) till 48 hours after the results are made public on July 28, 2021. We request you to kindly take the same on record. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended June 30, 2021, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 11.30 a.m. and concluded at 2.00 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record. (AS Per BSE Announcement Dated on 28.07.2021)
Board Meeting - 14-May-2021 - -
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, May 26, 2021, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2021 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2021. Pursuant to the Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders, the Trading Window of the Company was closed from Wednesday, March 31, 2021 (close of business) till 48 hours after the results are made public on May 26, 2021. We request you to kindly take the same on record. We submit herewith audited financial results for the financial year ended March 31, 2021, Statement of Assets and Liabilities as on March 31, 2021, Statement of Audited Cash Flows for the year ended March 31, 2021, Declaration with respect to Audit Report with unmodified opinion and the Auditors Report by Auditors, M/s. Walker Chandiok & Co LLP, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 2.15 p.m. and concluded at 4.00 p.m. Further, please be informed that the Board of Directors of the Company has recommended a normal dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) and a special dividend of Rs. 5/- per equity share of Rs. 10/- each (50%), aggregating to total dividend of Rs. 35/- per equity share of Rs. 10/- each (350%) for the year ended March 31, 2021. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 15, 2021. Please be informed that the Board of Directors of the Company has recommended a normal dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) and a special dividend of Rs. 5/- per equity share of Rs. 10/- each (50%), aggregating to total dividend of Rs. 35/- per equity share of Rs. 10/- each (350%) for the year ended March 31, 2021. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 15, 2021. (As Per BSE Announcement Dated 26.05.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity